Oric Pharmaceuticals, Inc. — Director's Dealing 2020

Apr 24, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Oric Pharmaceuticals, Inc. (ORIC)
CIK: 0001796280
Period of Report: 2020-04-23

Reporting Person: Heyman Richard A. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12500	Direct
Common Stock	165000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$		Common Stock (62500)		Indirect
Stock Option (right to buy)	$1.60	2028-02-28	Common Stock (46928)		Direct
Stock Option (right to buy)	$1.60	2028-06-28	Common Stock (18125)		Direct

Footnotes

F1: The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.

F2: The Series A Preferred Stock shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date.

F3: The shares subject to the option are fully vested and immediately exercisable.

F4: The option is subject to an early exercise provision and is immediately exercisable. One fourth (1/4th) of the shares subject to the option vested on May 10, 2019, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.